LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Vicenzi, Paige"
  2. AU="Schmid, Cordelia"
  3. AU="Zhiping Yuan" AU="Zhiping Yuan"
  4. AU="Szczepanska, Joanna"
  5. AU="Charmillon, Alexandre"
  6. AU=Chua Jia Xiang
  7. AU="Barber, T M"
  8. AU="Stipp, Christopher S"
  9. AU="Styczynski, Jan"
  10. AU="Schramm, Karl-Werner"
  11. AU="Mandhane, Piushkumar J"
  12. AU="Piraino, Domenica Carmen"
  13. AU="Owens, Janel E"
  14. AU="Vella, Kevin"
  15. AU="Eisenhaure, Thomas M"
  16. AU="Eggenberger, Caleb"
  17. AU="Choi, Seung-Hye"
  18. AU="Hans, B. T. Hackett S."
  19. AU="Singh, Ronak"
  20. AU=Forcados Gilead Ebiegberi
  21. AU="Kasperbauer, Jan L."
  22. AU="Xiang, Fangfei"
  23. AU=Bhattacharyya Rupam
  24. AU="Stefanski, R J"
  25. AU="Huiyuan Zhang"
  26. AU="Garg, Shivam Kumar"
  27. AU="Bart J. A. Rijnders"
  28. AU="Malaise, D"
  29. AU="Ahammad, Rijwan U"
  30. AU="Wong, Man Yu"
  31. AU="Yilmaz, Adnan"
  32. AU="Turkyilmaz, Ayberk"
  33. AU="Ryan, Sophia C"
  34. AU="Stino, Heiko"
  35. AU=Fischbeck K H
  36. AU="Giadinis, Nektarios D"
  37. AU="Patten, Scott"
  38. AU="Verma, Deepika"
  39. AU="Foo, Anthony Tun Lin"
  40. AU="Georgia Panagiotakos"
  41. AU="Tennankore, Karthik K."
  42. AU=Kubota Kenji
  43. AU="Vieille, Peggy"
  44. AU="Kan, Yin-Shi"
  45. AU="Jasińska-Balwierz, Agata"
  46. AU="Hargitai, Rita"
  47. AU=Ueda Kazumitsu
  48. AU="Andrew N. Jordan"
  49. AU="Millemaggi, Alessia"
  50. AU=Paulsen Paige
  51. AU="Fan, Su-Su"
  52. AU="de Azeredo, Andressa Cardoso"
  53. AU="Miller, Russell"
  54. AU="A Mombet"

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel ; Online: Comment on: Langerhans cell histiocytosis with BRAF p.N486_P490del or MAP2K1 p.K57_G61del treated by the MEK inhibitor trametinib.

    Vicenzi, Paige / Ray, Anish

    Pediatric blood & cancer

    2020  Band 68, Heft 4, Seite(n) e28776

    Mesh-Begriff(e) Histiocytosis, Langerhans-Cell/drug therapy ; Humans ; MAP Kinase Kinase 1/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Pyridones ; Pyrimidinones
    Chemische Substanzen Pyridones ; Pyrimidinones ; trametinib (33E86K87QN) ; BRAF protein, human (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; MAP Kinase Kinase 1 (EC 2.7.12.2) ; MAP2K1 protein, human (EC 2.7.12.2)
    Sprache Englisch
    Erscheinungsdatum 2020-10-21
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.28776
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Comment on: Curative-intent radiotherapy for pediatric osteosarcoma: The St. Jude experience.

    Vicenzi, Paige / Johnnidis, Melissa / Hamby, Tyler / Ray, Anish

    Pediatric blood & cancer

    2020  Band 67, Heft 6, Seite(n) e28287

    Mesh-Begriff(e) Child ; Humans ; Osteosarcoma ; Retrospective Studies
    Sprache Englisch
    Erscheinungsdatum 2020-04-15
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.28287
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care.

    Liu, Angela / Vicenzi, Paige / Sharma, Ishna / Orr, Kaci / Teller, Christa / Koentz, Micha / Trinkman, Heidi / Vallance, Kelly / Ray, Anish

    Hematology reports

    2023  Band 15, Heft 2, Seite(n) 244–255

    Abstract: The application of molecular tumor profiles in clinical decision making remains a challenge. To aid in the interpretation of complex biomarkers, molecular tumor boards (MTBs) have been established worldwide. In the present study, we show that a ... ...

    Abstract The application of molecular tumor profiles in clinical decision making remains a challenge. To aid in the interpretation of complex biomarkers, molecular tumor boards (MTBs) have been established worldwide. In the present study, we show that a multidisciplinary approach is essential to the success of MTBs. Our MTB, consisting of pediatric oncologists, pathologists, and pharmacists, evaluated 115 cases diagnosed between March 2016 and September 2021. If targetable mutations were identified, pharmacists aided in the evaluation of treatment options based on drug accessibility. Treatable genetic alterations detected through molecular testing most frequently involved the cell cycle. For 85% of the cases evaluated, our MTB provided treatment recommendations based on the patient's history and results of molecular tumor testing. Only three patients, however, received MTB-recommended targeted therapy, and only one of these patients demonstrated an improved clinical outcome. For the remaining patients, MTB-recommended treatment often was not administered because molecular tumor profiling was not performed until late in the disease course. For the three patients who did receive MTB-recommended therapy, such treatment was not administered until months after diagnosis due to physician preference. Thus, the education of healthcare providers regarding the benefits of targeted therapy may increase acceptance of these novel agents and subsequently improve patient survival.
    Sprache Englisch
    Erscheinungsdatum 2023-04-04
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article
    ZDB-ID 2586645-X
    ISSN 2038-8330 ; 2038-8322
    ISSN (online) 2038-8330
    ISSN 2038-8322
    DOI 10.3390/hematolrep15020025
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Comment on: The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis.

    Vicenzi, Paige / Jiwani, Zahra / Guirola, Ricardo / Hamby, Tyler / Ray, Anish

    Pediatric blood & cancer

    2020  Band 68, Heft 4, Seite(n) e28813

    Mesh-Begriff(e) Humans ; Interleukin 1 Receptor Antagonist Protein ; Lymphohistiocytosis, Hemophagocytic/drug therapy ; Multiple Organ Failure ; Retrospective Studies
    Chemische Substanzen Interleukin 1 Receptor Antagonist Protein
    Sprache Englisch
    Erscheinungsdatum 2020-11-16
    Erscheinungsland United States
    Dokumenttyp Letter ; Comment
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.28813
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang